Coal tar
This article was originally published in The Tan Sheet
Executive Summary
FDA response to citizen petition requesting coal tar-containing products be restricted to Rx-only sales expected by Jan. 22. Perry Gottesfeld, a plaintiff in California Proposition 65 litigation against product manufacturers, asked the agency in March to conduct a "formal review" of coal tar's use in shampoo, soap and ointments. Consolidated trial in separate Prop 65 lawsuits brought by the state and Gottesfeld was stayed until Jan. 29 following defense requests the trial be postponed pending FDA's review (1"The Tan Sheet" Sept. 4, p. 16)
You may also be interested in...
Coal Tar Absorption Rates Pose Cancer Risk, California AG Data Indicate
High usage rates of coal tar-containing shampoos and soaps could expose people to an increased risk of cancer, according to data provided to FDA by California Attorney General Bill Lockyer.
California Coal Tar Litigation Stay Sought Pending FDA Petition Review
California litigation over the use of coal tar in dandruff shampoos and other OTCs should be stayed pending FDA review of the ingredient's safety, drug distributor Bergen Brunswig tells a San Francisco judge.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC